How do you take a scientific hunch and turn it into a breakthrough that could change medicine forever? In this episode of Wild Hearts, we sit down with Elise Jenkins, co-founder of Opto Biosystems, to discuss the journey of building a first-in-class brain implant that merges neurotechnology with oncology.  🎧 Subscribe on Apple or Spotify to learn. We explore the highs and lows of moving from academia to a high-stakes startup, the unexpected hurdles of working with neurosurgeons, and the race toward first-in-human trials. In this conversation, we cover: 🧠 Bridging the gap between neuroscience and cancer research 🔬 How brain-Computer interfaces could transform oncology 📈 The road to the first-in-human clinical trials and what It means for the future 💡 The challenges of moving from academia to a high-impact startup ⚡ Why the next generation of neural implants need to be MRI-invisible  🏥 What It takes to get regulatory approval for a revolutionary medical implant  🌎 Opto’s long-term vision: using neural biomarkers beyond brain cancer If you're fascinated by the intersection of science, engineering, and medicine, this conversation is for you. 🎧 Subscribe on Apple or Spotify to learn.